Heart Test Laboratories, Inc. EBIT for the Trailing 12 Months (TTM) ending July 31, 2022: USD -5.46 M

Heart Test Laboratories, Inc. EBIT is USD -5.46 M for the Trailing 12 Months (TTM) ending July 31, 2022. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
Key Data
Date EBIT EBITDA Net Income EPS (Diluted)